Kissei Pharmaceutical Co., Ltd. (4547.T)
JPY 3775.0
(-1.82%)
JPY 3775.0
(-1.82%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 75.57 Billion JPY | 11.98% |
| 2022 | 67.49 Billion JPY | 3.23% |
| 2021 | 65.38 Billion JPY | -5.31% |
| 2020 | 69.04 Billion JPY | 9.17% |
| 2019 | 63.24 Billion JPY | -12.53% |
| 2018 | 72.3 Billion JPY | -2.29% |
| 2017 | 73.99 Billion JPY | 3.19% |
| 2016 | 71.7 Billion JPY | 0.58% |
| 2015 | 71.29 Billion JPY | 1.7% |
| 2014 | 70.1 Billion JPY | -0.41% |
| 2013 | 70.4 Billion JPY | 12.65% |
| 2012 | 62.49 Billion JPY | -3.36% |
| 2011 | 64.66 Billion JPY | 0.44% |
| 2010 | 64.38 Billion JPY | 3.62% |
| 2009 | 62.13 Billion JPY | -3.72% |
| 2008 | 64.53 Billion JPY | 4.98% |
| 2007 | 61.47 Billion JPY | -4.21% |
| 2006 | 64.17 Billion JPY | 0.26% |
| 2005 | 64.01 Billion JPY | 5.05% |
| 2004 | 60.93 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 21.3 Billion JPY | 0.65% |
| 2024 Q1 | 21.16 Billion JPY | 19.44% |
| 2023 Q2 | 17.66 Billion JPY | -8.53% |
| 2023 Q1 | 19.31 Billion JPY | 21.79% |
| 2023 FY | 75.57 Billion JPY | 11.98% |
| 2023 Q3 | 20.88 Billion JPY | 18.21% |
| 2023 Q4 | 17.72 Billion JPY | -15.14% |
| 2022 Q1 | 16.28 Billion JPY | 6.47% |
| 2022 FY | 67.49 Billion JPY | 3.23% |
| 2022 Q2 | 16.57 Billion JPY | 1.81% |
| 2022 Q3 | 18.77 Billion JPY | 13.22% |
| 2022 Q4 | 15.85 Billion JPY | -15.52% |
| 2021 Q2 | 15.75 Billion JPY | -5.3% |
| 2021 Q3 | 17.69 Billion JPY | 12.34% |
| 2021 FY | 65.38 Billion JPY | -5.31% |
| 2021 Q4 | 15.29 Billion JPY | -13.57% |
| 2021 Q1 | 16.63 Billion JPY | -1.28% |
| 2020 Q1 | 16.06 Billion JPY | 9.4% |
| 2020 Q3 | 19.91 Billion JPY | 22.74% |
| 2020 FY | 69.04 Billion JPY | 9.17% |
| 2020 Q4 | 16.85 Billion JPY | -15.36% |
| 2020 Q2 | 16.22 Billion JPY | 0.99% |
| 2019 Q1 | 16.11 Billion JPY | -5.47% |
| 2019 Q4 | 14.68 Billion JPY | -13.65% |
| 2019 Q3 | 17 Billion JPY | 10.05% |
| 2019 FY | 63.24 Billion JPY | -12.53% |
| 2019 Q2 | 15.45 Billion JPY | -4.1% |
| 2018 FY | 72.3 Billion JPY | -2.29% |
| 2018 Q3 | 19.58 Billion JPY | 9.95% |
| 2018 Q4 | 17.04 Billion JPY | -12.99% |
| 2018 Q1 | 17.85 Billion JPY | 3.72% |
| 2018 Q2 | 17.81 Billion JPY | -0.24% |
| 2017 FY | 73.99 Billion JPY | 3.19% |
| 2017 Q4 | 17.21 Billion JPY | -14.74% |
| 2017 Q3 | 20.19 Billion JPY | 13.83% |
| 2017 Q2 | 17.74 Billion JPY | -5.87% |
| 2017 Q1 | 18.84 Billion JPY | 10.23% |
| 2016 FY | 71.7 Billion JPY | 0.58% |
| 2016 Q1 | 19.15 Billion JPY | 9.19% |
| 2016 Q2 | 16.67 Billion JPY | -12.95% |
| 2016 Q3 | 18.77 Billion JPY | 12.56% |
| 2016 Q4 | 17.09 Billion JPY | -8.92% |
| 2015 Q1 | 16.68 Billion JPY | -4.64% |
| 2015 Q3 | 20.15 Billion JPY | 19.12% |
| 2015 Q2 | 16.91 Billion JPY | 1.42% |
| 2015 Q4 | 17.54 Billion JPY | -12.93% |
| 2015 FY | 71.29 Billion JPY | 1.7% |
| 2014 Q1 | 15.83 Billion JPY | -7.12% |
| 2014 FY | 70.1 Billion JPY | -0.41% |
| 2014 Q4 | 17.49 Billion JPY | -2.88% |
| 2014 Q3 | 18.01 Billion JPY | -4.04% |
| 2014 Q2 | 18.76 Billion JPY | 18.53% |
| 2013 Q4 | 17.04 Billion JPY | -20.45% |
| 2013 FY | 70.4 Billion JPY | 12.65% |
| 2013 Q1 | 16.3 Billion JPY | 2.01% |
| 2013 Q2 | 15.61 Billion JPY | -4.22% |
| 2013 Q3 | 21.43 Billion JPY | 37.22% |
| 2012 Q3 | 17.18 Billion JPY | 15.0% |
| 2012 FY | 62.49 Billion JPY | -3.36% |
| 2012 Q2 | 14.94 Billion JPY | 3.94% |
| 2012 Q1 | 14.37 Billion JPY | -10.42% |
| 2012 Q4 | 15.98 Billion JPY | -7.01% |
| 2011 Q1 | 15.52 Billion JPY | -8.57% |
| 2011 FY | 64.66 Billion JPY | 0.44% |
| 2011 Q2 | 16.32 Billion JPY | 5.21% |
| 2011 Q3 | 16.76 Billion JPY | 2.68% |
| 2011 Q4 | 16.05 Billion JPY | -4.26% |
| 2010 Q4 | 16.97 Billion JPY | 3.19% |
| 2010 Q1 | 15.84 Billion JPY | 8.34% |
| 2010 FY | 64.38 Billion JPY | 3.62% |
| 2010 Q2 | 15.11 Billion JPY | -4.66% |
| 2010 Q3 | 16.45 Billion JPY | 8.87% |
| 2009 Q2 | 15.89 Billion JPY | 0.75% |
| 2009 Q4 | 14.62 Billion JPY | -7.64% |
| 2009 Q3 | 15.83 Billion JPY | -0.34% |
| 2009 Q1 | 15.77 Billion JPY | -13.73% |
| 2009 FY | 62.13 Billion JPY | -3.72% |
| 2008 Q2 | 15.1 Billion JPY | 0.0% |
| 2008 FY | 64.53 Billion JPY | 4.98% |
| 2008 Q3 | 15.95 Billion JPY | 5.65% |
| 2008 Q4 | 18.28 Billion JPY | 14.59% |
| 2007 FY | 61.47 Billion JPY | -4.21% |
| 2006 FY | 64.17 Billion JPY | 0.26% |
| 2005 FY | 64.01 Billion JPY | 5.05% |
| 2004 FY | 60.93 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 62.14 Billion JPY | -21.613% |
| Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 98.227% |
| Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | 75.973% |
| Shionogi & Co., Ltd. | 435.08 Billion JPY | 82.629% |
| Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -876.671% |
| Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | 49.021% |
| Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | -4.907% |
| Eisai Co., Ltd. | 741.75 Billion JPY | 89.811% |
| Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -509.213% |
| Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | 46.665% |
| Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | 26.54% |
| Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | -36.409% |
| Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | -145.801% |
| Tsumura & Co. | 150.84 Billion JPY | 49.896% |
| Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | -38.327% |
| Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | 66.842% |
| Fuji Pharma Co., Ltd. | 40.88 Billion JPY | -84.839% |
| Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | 0.193% |
| KYORIN Holdings, Inc. | 119.53 Billion JPY | 36.771% |
| Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -1399.583% |
| Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | -61.166% |
| SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -1252.11% |
| MedRx Co., Ltd | 26 Million JPY | -290588.462% |
| Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -587.724% |
| Solasia Pharma K.K. | 617 Million JPY | -12149.433% |
| Modalis Therapeutics Corporation | - JPY | -Infinity% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | -20.266% |
| Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | 57.267% |
| Cyfuse Biomedical K.K. | 61.11 Million JPY | -123572.928% |
| Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 94.882% |
| Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | -241.459% |